Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-367P is classified as a pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNA is an essential non-coding RNA component of the spliceosome involved in pre-mRNA splicing. However, as a pseudogene, RNU6-367P does not produce a functional RNA transcript and is not implicated in splicing or other known cellular processes. Pseudogenes can arise from retrotransposition events and may serve as genomic markers of such dynamics or have minor regulatory roles, but RNU6-367P itself is annotated solely as an inactive, non-functional locus with no attributed protein, disease, or drug target relevance[7][4][6]. This molecule is not a receptor, enzyme, transporter, or traditional therapeutic target; instead, it belongs to the molecular class of non-coding pseudogenes in the human genome[7][6][4].
Mechanism not applicable, as the molecule does not mediate any known pharmacological interactions or functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 367, pseudogene (RNU6-367P).